Troza, Lolita .
HRN: 23-84-13 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/07/2023
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
10/07/2023
10/14/2023
IV
500mg
OD
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractPneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes